エドガーで原本を確認する
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission File Number 001-37381
XYLO
TECHNOLOGIES LTD.
(Translation of registrant’s name into English)
10 HaNechoshet Street, Tel-Aviv, 6971072, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On April 22, 2024, Xylo Technologies Ltd. issued a press release titled: “Xylo Technologies Files its 2023 Annual Report on Form 20-F.” A copy of this press release is furnished herewith as Exhibit 99.1.
EXHIBIT INDEX
| Exhibit | Description | |
| 99.1 | Press release dated April 22, 2024 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| XYLO TECHNOLOGIES LTD. | ||
| Date: April 22, 2024 | By: | /s/ Tali Dinar |
| Tali Dinar | ||
| Chief Financial Officer | ||
3
Exhibit 99.1
Xylo Technologies Files its 2023 Annual Report on Form 20-F
TEL AVIV, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”, or the “Company”), formerly known as Medigus Ltd., a technology-based company engaged in advanced innovative technologies, announced the filing of its 2023 Annual Report on Form 20-F with the Securities and Exchange Commission.
Xylo’s 2023 Annual Report on Form 20-F includes audited financial statements for the year ended December 31, 2023. The report can be accessed on the company’s investor relations website and on the SEC’s website at www.sec.gov.
About Xylo
Based in Israel, Xylo Technologies Ltd. (Nasdaq: XYLO) is a technologies company that focuses on innovative growth partnerships, mainly in advanced medical solutions, digital commerce, and electric vehicle markets. Xylo’s affiliations in the medical solutions arena include the ownership in Polyrizon Ltd. Xylo’s affiliates in digital commerce include Gix Internet Ltd., Jeffs’ Brands and Eventer Technologies Ltd. In the electric vehicle market, Fuel Doctor, Inc., Charging Robotics, Ltd. and Revoltz Ltd. are also part of Xylo’s portfolio of technology solution providers. Other affiliations of Xylo include Parazero Technologies Ltd. and Zig Miami 54 LLC.
Xylo is traded on the Nasdaq Capital Market. To learn more about Xylo’s advanced technologies, please visit http://www.medigus.com/investor-relations
Company Contact:
Tali Dinar
Chief Financial Officer
ir@medigus.com
Investor Relations Contact:
Michal Efraty
Investor Relations,
michal@efraty.com